Novo Holdings has completed the previously announced acquisition of Catalent in a $16.5bn all-cash transaction. The European ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been ...

Bill Holdings, Inc. ($BILL) stock rose sharply in Thursday’s premarket session, reacting to the news of index inclusion but ...

The Comstock Capital Value Fund (class I) returned 4.16% for the third quarter of 2024. Click here to read the full ...

Henrik Wulff, the man in charge of product supply at Novo Nordisk, just spent $11 billion to try to fill an ocean. Novo has ...

S&P MidCap 400 constituent Lennox International Inc. (NYSE: LII) will replace Catalent Inc. (NYSE: CTLT) in the S&P 500, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of ...

Prothena stock catapulted Thursday after the company's Roche-partnered Parkinson's treatment showed promise in a midstage ...

The 2022 Inflation Reduction Act (IRA) has introduced significant challenges for the pharmaceutical industry, altering the ...

Vertex Pharmaceuticals reported that its non-opioid drug reduced back pain significantly. But Vertex stock plunged as a ...

U.S. stock index futures on Thursday climbed, as Wall Street looked to rebound from a sharp Federal Reserve-induced sell-off from the previous day. Here are some stocks to watch on Thursday: ...